All news

NeurAxis revenue jumps 150% but net loss widens

Alpha Vantage · scanx.trade · · AI-summarised by FinFlash

NeurAxis reported Q3FY26 revenue of $2.0 million, up 150% year over year, driven by expanded insurance coverage for its IB-Stim device and its Category I CPT code. Gross margins improved, but the net loss widened to $6.5 million, largely due to $4.3 million in one-time stock compensation charges.

Read original source

NRXS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.